Chronic heart failure
... cm from the outside of the midclavicular line. Cardiac deaf. Heart rate - 100 per min. BP 140/90 mm Hg. Liver 4 cm below the right upper quadrant. Radiological findings: heart extended to the left and down, determined paradoxical pulse. ECG - focal cicatricial changes in the anterior wall of the lef ...
... cm from the outside of the midclavicular line. Cardiac deaf. Heart rate - 100 per min. BP 140/90 mm Hg. Liver 4 cm below the right upper quadrant. Radiological findings: heart extended to the left and down, determined paradoxical pulse. ECG - focal cicatricial changes in the anterior wall of the lef ...
Exercise and Heart Failure
... used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggestive of HF. To date, efficacious therapies have not been identified. ...
... used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggestive of HF. To date, efficacious therapies have not been identified. ...
CV-2-2014
... fill it more fully with blood. The increased stretch of the ventricle will align its actin and myosin in a more optimal pattern of overlap. ...
... fill it more fully with blood. The increased stretch of the ventricle will align its actin and myosin in a more optimal pattern of overlap. ...
ECG Quiz 24
... Answer: Complete heart block with LBBB pattern. He actually has a pacemaker in which is difficult to tell from this ECG so the LBBB is because of the pacemaker lead. You can tell its complete heart block with the following rules 1. Regular P-P interval 2. Regular R-R interval 3. The PR interval is ...
... Answer: Complete heart block with LBBB pattern. He actually has a pacemaker in which is difficult to tell from this ECG so the LBBB is because of the pacemaker lead. You can tell its complete heart block with the following rules 1. Regular P-P interval 2. Regular R-R interval 3. The PR interval is ...
Slide 1
... Patients presenting with breathlessness and patients on the listed chronic disease registers, attending for routine review, should be asked to complete an NYHA questionnaire while waiting to see the practice Nurse / doctor. Those whose answers suggest that they are in NYHA II or above should have a ...
... Patients presenting with breathlessness and patients on the listed chronic disease registers, attending for routine review, should be asked to complete an NYHA questionnaire while waiting to see the practice Nurse / doctor. Those whose answers suggest that they are in NYHA II or above should have a ...
Slide 1
... Guideline: AF and CHF Class III:Harm 1. AV node ablation should not be performed without a pharmacological trial to achieve ventricular rate control 2. For rate control, intravenous nondihydropyridine calcium channel antagonists, intravenous beta blockers, and dronedarone should not be administered ...
... Guideline: AF and CHF Class III:Harm 1. AV node ablation should not be performed without a pharmacological trial to achieve ventricular rate control 2. For rate control, intravenous nondihydropyridine calcium channel antagonists, intravenous beta blockers, and dronedarone should not be administered ...
Interventions for Clients with Cardiac Problems
... Because cardiac output is the product of heart rate and stroke volume, an increase in heart rate results in an immediate increase in cardiac output. An increase in heart rate is limited in its ability to compensate for decreased cardiac output. If heart rate becomes too rapid, diastolic filling time ...
... Because cardiac output is the product of heart rate and stroke volume, an increase in heart rate results in an immediate increase in cardiac output. An increase in heart rate is limited in its ability to compensate for decreased cardiac output. If heart rate becomes too rapid, diastolic filling time ...
Primary hypoparathyroidism presenting with
... values returned to normal during this period (Table 1). The suspicion of a PHPT was confirmed through the PTH value, which was found to be 0.5 pg/ml (normal values 11 – 54 pg/ml), thus significantly below normal, on a sample taken the day of admission. Calcitriol was added the second day of infusion t ...
... values returned to normal during this period (Table 1). The suspicion of a PHPT was confirmed through the PTH value, which was found to be 0.5 pg/ml (normal values 11 – 54 pg/ml), thus significantly below normal, on a sample taken the day of admission. Calcitriol was added the second day of infusion t ...
Cardiff Met research project provides insights into heart health of
... who manages the project at Cardiff Metropolitan University and has a clinical background in human cardiac ultrasound. As part of their research, they have assisted the Jane Goodall Institute in the Republic of Congo in screening for heart disease in animals that are being rehabilitated. The Jane Goo ...
... who manages the project at Cardiff Metropolitan University and has a clinical background in human cardiac ultrasound. As part of their research, they have assisted the Jane Goodall Institute in the Republic of Congo in screening for heart disease in animals that are being rehabilitated. The Jane Goo ...
Atrial Fibrillation Treatment
... times, both at rest and during exertion. Some patients have such fast heart rates during AFib that with time the heart can become weak – and develop congestive heart failure. It is always one of the goals of our therapy to prevent congestive heart failure. The majority of patients will have their he ...
... times, both at rest and during exertion. Some patients have such fast heart rates during AFib that with time the heart can become weak – and develop congestive heart failure. It is always one of the goals of our therapy to prevent congestive heart failure. The majority of patients will have their he ...
hypertrophic cardiomyopathy
... Hypertrophic cardiomyopathy is a heart disease characterized by increased thickness of the heart muscle. At the same time, the muscle cells themselves are unorganized or in disarray. This disease occurs in some fashion in approximately 1 out of 500 individuals. In many instances it is unrecognized a ...
... Hypertrophic cardiomyopathy is a heart disease characterized by increased thickness of the heart muscle. At the same time, the muscle cells themselves are unorganized or in disarray. This disease occurs in some fashion in approximately 1 out of 500 individuals. In many instances it is unrecognized a ...
VADs - St. Peter`s Health Partners
... advanced heart disease, such as heart failure. The most appropriate treatment for each patient is based on the severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart d ...
... advanced heart disease, such as heart failure. The most appropriate treatment for each patient is based on the severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart d ...
VADs - St. Peter`s Hospital
... advanced heart disease, such as heart failure. The most appropriate treatment for each patient is based on the severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart d ...
... advanced heart disease, such as heart failure. The most appropriate treatment for each patient is based on the severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart d ...
Heart Failure With Preserved Ejection Fraction
... hypertension. Importantly, because the impairment in contractility in HFpEF is mild, it is unlikely to be the culprit mechanism that underlies the pathogenesis of HFpEF. Instead, the authors speculate that the impaired contractility in HFpEF is due to other alterations in myocardial structure and fu ...
... hypertension. Importantly, because the impairment in contractility in HFpEF is mild, it is unlikely to be the culprit mechanism that underlies the pathogenesis of HFpEF. Instead, the authors speculate that the impaired contractility in HFpEF is due to other alterations in myocardial structure and fu ...
Nuclear Cardiology Foundation
... shortness of breath, several of the lesser-known symptoms of heart disease may include nausea, fatigue, and pain in the arm, back, or neck. ...
... shortness of breath, several of the lesser-known symptoms of heart disease may include nausea, fatigue, and pain in the arm, back, or neck. ...
Drug-Free Correction of the Tone of the Autonomic Nervous System
... according to the LF/HF index compared with group B (2.43 ± 0.78 versus 1.85 ± 0.20, respectively). Immediately post VNES therapy, the LF/HF index in group A was 1.25 ± 0.25, which was significantly lower than it was prior to the treatment (p=0.001). The autonomic nervous balance in group B did not s ...
... according to the LF/HF index compared with group B (2.43 ± 0.78 versus 1.85 ± 0.20, respectively). Immediately post VNES therapy, the LF/HF index in group A was 1.25 ± 0.25, which was significantly lower than it was prior to the treatment (p=0.001). The autonomic nervous balance in group B did not s ...
New Developments and Expansion of Cardiology Services at the
... welcomes the new appointment. “Dr. Morrice, has recently returned from Belgium where he worked in one of the most advanced cardiac centres in Europe. He brings with him invaluable Electrophysiology expertise, specialising in Cardiac Arrhythmias, ablation, insertion of pacemakers and automatic implan ...
... welcomes the new appointment. “Dr. Morrice, has recently returned from Belgium where he worked in one of the most advanced cardiac centres in Europe. He brings with him invaluable Electrophysiology expertise, specialising in Cardiac Arrhythmias, ablation, insertion of pacemakers and automatic implan ...
Surgery in Wolff-Parkinson-White Syndrome
... described in 1930,1 consists of a characteristic electrocardiographic abnormality in people who are prone to paroxysmal tachycardia. The electrocardiogram shows a short PR interval with a widened QRS complex, the first part of which is characteristically slurred. Though initially thought to represen ...
... described in 1930,1 consists of a characteristic electrocardiographic abnormality in people who are prone to paroxysmal tachycardia. The electrocardiogram shows a short PR interval with a widened QRS complex, the first part of which is characteristically slurred. Though initially thought to represen ...
Practice Questions - Answers Which of the following is not an effect
... end of diastole respectively, typically in the setting of heart disease (but not always). Postulate the underlying mechanical cause of both these extra sounds. The point of this question was more to get you thinking about the origins of heart sounds, and realizing that not always do they occur due t ...
... end of diastole respectively, typically in the setting of heart disease (but not always). Postulate the underlying mechanical cause of both these extra sounds. The point of this question was more to get you thinking about the origins of heart sounds, and realizing that not always do they occur due t ...
Mortality in heart failure with preserved ejection fraction: an
... which was interpreted as reflecting the introduction and adoption of new medical therapies and implantable cardioverterdefibrillators (ICDs) over this time period. However, the concept of similar mortality in HFpEF and HFrEF was recently challenged in a literature-based meta-analysis that included 1 ...
... which was interpreted as reflecting the introduction and adoption of new medical therapies and implantable cardioverterdefibrillators (ICDs) over this time period. However, the concept of similar mortality in HFpEF and HFrEF was recently challenged in a literature-based meta-analysis that included 1 ...
Noninvasive Cardiac Output
... Guiding therapy by traditional parameters makes it very difficult to decide whether volume, inotropes, or vasopressors would be best for the patient. With the ICON and AESCULON, the user gets a complete picture of the patient hemodynamics using a method that is quick, easy, safe, non Invasive and ac ...
... Guiding therapy by traditional parameters makes it very difficult to decide whether volume, inotropes, or vasopressors would be best for the patient. With the ICON and AESCULON, the user gets a complete picture of the patient hemodynamics using a method that is quick, easy, safe, non Invasive and ac ...
Heart
... short bursts of 200-300 bpm but coordinated 4. fibrillation rapid, uncoordinated contractions of individual muscle cells atrial fibrillation is OK (since it only contributes 20% of blood to heart beat) ventricular fibrillation is lethal electrical shock used to defibrillate and recoordinate contract ...
... short bursts of 200-300 bpm but coordinated 4. fibrillation rapid, uncoordinated contractions of individual muscle cells atrial fibrillation is OK (since it only contributes 20% of blood to heart beat) ventricular fibrillation is lethal electrical shock used to defibrillate and recoordinate contract ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.